Dianthus Therapeutics (DNTH) Amortizatization of Intangibles (2019 - 2025)
Dianthus Therapeutics (DNTH) recorded quarterly Amortizatization of Intangibles of $2.3 million in Q3 2025, up 110.47% quarter-over-quarter from $1.1 million in Q2 2025, and down 1.28% on a YoY basis from $2.3 million in Q3 2024.
Dianthus Therapeutics (DNTH) Amortizatization of Intangibles (2019 - 2025) Analysis & Trends
Dianthus Therapeutics' Amortizatization of Intangibles history runs 7 years deep, the most recent figure standing at $2.3 million for Q3 2025.
- In Q3 2025, Amortizatization of Intangibles fell 1.28% year-over-year to $2.3 million; the TTM figure through Sep 2025 stood at $3.6 million (up 33.45% YoY), while the FY2024 annual figure was $316000.0, up 9.72% from the prior year.
- Amortizatization of Intangibles was $2.3 million for Q3 2025 at Dianthus Therapeutics, up from $1.1 million in the prior quarter.
- In the past five years, Amortizatization of Intangibles ranged from a high of $2.3 million in Q3 2024 to a low of -$608000.0 in Q4 2023.
- Historically, Amortizatization of Intangibles has averaged $370210.5 across 5 years, with a median of $106000.0 in 2025.
- The sharpest annual moves came in 2021 and 2022: Amortizatization of Intangibles plunged 1442.86% in 2021, then jumped 775.64% in 2022.
- A 5-year view of Amortizatization of Intangibles shows it stood at -$78000.0 in 2021, then soared by 775.64% to $527000.0 in 2022, then sank by 215.37% to -$608000.0 in 2023, then jumped by 108.55% to $52000.0 in 2024, then soared by 4344.23% to $2.3 million in 2025.
- The last three Amortizatization of Intangibles figures came in at $2.3 million (Q3 2025), $1.1 million (Q2 2025), and $106000.0 (Q1 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 13,267.00 |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Dianthus Therapeutics | 3.60 Bn | 3.19 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 2.31 Mn |
| Sep 30, 2025 | 2.31 Mn |
| Jun 30, 2025 | 1.10 Mn |
| Jun 30, 2025 | 1.10 Mn |
| Mar 31, 2025 | 106,000.00 |
| Mar 31, 2025 | 106,000.00 |
| Dec 31, 2024 | 52,000.00 |
| Dec 31, 2024 | 52,000.00 |
| Sep 30, 2024 | 2.34 Mn |
| Sep 30, 2024 | 2.34 Mn |
| Jun 30, 2024 | 422,000.00 |
| Jun 30, 2024 | 422,000.00 |
| Mar 31, 2024 | 518,000.00 |
| Mar 31, 2024 | 518,000.00 |
| Dec 31, 2023 | -608,000.00 |
| Dec 31, 2023 | -608,000.00 |
| Sep 30, 2023 | 330,000.00 |
| Sep 30, 2023 | 330,000.00 |
| Jun 30, 2023 | 499,000.00 |
| Jun 30, 2023 | 499,000.00 |